Yaoxue Xuebao

Submission On

( Vol 60 , Issue 04 ) |

27 Dec 2025
Day
Hour
Min
Sec
Publish On

( Vol 60 , Issue 04 ) |

31 Dec 2025
Scopus Indexed (2026) scopus
ABCD Indexed (2025) scopus
scopus

Yaoxue Xuebao

Yaoxue Xuebao (ISSN:0513-4870) is a monthly peer-reviewed scopus-indexed journal from 1960, from 1962 to 1966, from 1979 to Present. The publisher of this journal is Chinese Pharmaceutical Association. Yaoxue Xuebao committed to gathering and disseminating excellent research achievements. The journal welcomes all kind of research/review/abstract papers regarding Pharmacology, Toxicology and Pharmaceutics, General Pharmacology and Toxicology and Pharmaceutics Biochemistry, Genetics and Molecular Biology and Molecular Medicine and so on.

Aim And Scope

Yaoxue Xuebao

Pharmacology

Toxicology and Pharmaceutics

General Pharmacology

Toxicology and Pharmaceutics Biochemistry

Genetics and Molecular Biology

Molecular Medicine

Latest Journal

Yaoxue Xuebao

  • YX-18-11-2024-2118
  • | Yaoxue Xuebao (ISSN:0513-4870)

Global progress in peptide radiopharmaceutical research and China's opportunities

Radiopharmaceutical is an essential component of nuclear medicine and molecular imaging, as well as a key component of precision medicine. The United States Food and Drug Administration (FDA) has recently approved the marketing of several peptide-based radiopharmaceuticals, sparking a global trend of research in this area and propelling nuclear medicine into the precision theranostic era. This has created a new wave of technological competition in the field of nuclear medicine. It is the responsibility of Chinese scientists in the radiopharmaceutical field to capitalize on this opportunity,

read more..
  • YX-18-11-2024-2117
  • | Yaoxue Xuebao (ISSN:0513-4870)

Research progress on cardiovascular toxicity associated with anti-tumor drugs and its prevention and treatment

Cancer and cardiovascular diseases are the two major causes of death worldwide. The application of anti-tumor drugs has significantly improved the prognosis of patients, the cardiovascular toxicity caused by the application of them has become an important factor affecting the survival and prognosis of cancer patients. Therefore, the prevention and treatment of cardiovascular toxicity related to cancer treatment is increasingly important. The cardiovascular toxicity associated with anti-tumor drugs exhibits different clinical manifestations and involves multiple pathological mechanisms. This

read more..
  • YX-18-11-2024-2116
  • | Yaoxue Xuebao (ISSN:0513-4870)

Development of a method for determination of progesterone sustained-release formulation in Beagle dog plasma and its pharmacokinetic study

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to determine the plasma concentration of progesterone in Beagle dogs, and apply it to the study of the pharmacokinetics of progesterone sustained-release formulation in Beagle dogs. The plasma samples were processed by protein precipitation method and megestrol acetate was used as an internal standard (IS). The quantification analysis was performed using multiple-reaction monitoring (MRM) mode at the specific ion transitions of m/z 315.2→97.0 for progesterone and m/z 385.2→267.1 for megestrol acetate

read more..
  • YX-18-11-2024-2115
  • | Yaoxue Xuebao (ISSN:0513-4870)

Characterization and phylogenetic analysis of the complete chloroplast genome of Lycopus europaeus

We intend to study the structural characteristics of Lycopus europaeus Linn. chloroplast genome and compare the evolutionary relationship of species from Lamiaceae with similar medicinal effects. The total DNA of Lycopus europaeus was sequenced using the Illumina Hiseq 4000 Sequencing platform and was assembled using NOVOplasty software. And then we annotated and analyzed the genome using the CPGAVAS2 online tool. We constructed the phylogenetic tree using the Stellera chamaejasme and Potentilla chinensis as the outgroup. The entire length of Lycopus europaeus chloroplast genome was 152 085

read more..
  • YX-18-11-2024-2113
  • | Yaoxue Xuebao (ISSN:0513-4870)

Research on the antioxidant activity of metabolites from a sponge-derived fungus Alternaria sp.

To study the chemical constituents from the deep-sea fungus Alternaria sp. F49. Seven compounds were isolated from the EtOAc extract by using silica gel, Sephadex LH-20, ODS and HPLC methods. Based on the spectroscopic analysis, their structures were identified as (8R)-5-O-methyl-orcinotriol (1), orcinotriol (2), α-acetylorcinol (3), 3'-hydroxyalternariol 5-O-methyl ether (4), altenusiol (5), altenusin (6), and 5'-methoxy-6-methyl-biphenyl-3,4,3'-triol (7). (8R)-5-O-Methyl-orcinotriol (1) is a new phenolic compound which has never been reported in the literature. Compounds

read more..

The publisher of this journal is Chinese Pharmaceutical Association. Yaoxue Xuebao committed to gathering and disseminating excellent research achievements.

Information
Guidelines
Contact Us
  • journalpublication435@gmail.com
  • admin@yaoxuexuebao-05134870.com
  • support@yaoxuexuebao-05134870.com
All rights reserved | © 2024 Yaoxue Xuebao (ISSN:0513-4870).